Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
71.63
+0.09 (0.13%)
Dec 5, 2025, 4:00 PM EST - Market closed
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $10.79 billion as of December 5, 2025. Its market cap has increased by 118.77% in one year.
Market Cap
10.79B
Enterprise Value
8.97B
1-Year Change
118.77%
Ranking
Category
Stock Price
$71.63
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $10.79B, an increase of 971.26%. That is a compound annual growth rate of 54.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 10.78B | 210.69% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |